This analysis describes what Writer's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The updated terms establish clearer scope (these terms apply to free, trial, and paid versions; Enterprise is separate) and expand the list of prohibited uses. Users may no longer reverse engineer, scrape, or attempt to derive components of the Services; use the platform for competitive analysis or to develop competing products; or misrepresent AI-generated output as human-created. The terms also explicitly prohibit processing of HIPAA-regulated health information. Users can review the full updated terms to understand which specific uses are now restricted.
View change record →How other platforms handle this
You may not reverse engineer or reverse compile any of our Services or the technology used to operate our Services.
Teladoc Health grants you a limited, non-exclusive, non-sublicensable, revocable, non-transferable license to use the Platforms in accordance with these Terms and Conditions.
Subject to the terms of this Agreement, Customer hereby grants to Anyscale and its Affiliates a non-exclusive, worldwide, royalty-free right and license to process the Customer Property solely to the extent necessary to provide the Anyscale Services...
"We own all rights, title, and interest in and to our Services, including but not limited to, our Platform, including its underlying software, including model weights, parameters, algorithms, interfaces, technology...Excerpt from Writer's Terms of Service
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
The clause states: “We own all rights, title, and interest in and to our Services, including but not limited to, our Platform, including its underlying software, including model weights, parameters, algorithms, interfaces, technology...”
ConductAtlas has identified this type of provision across 250 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Writer.